Home
News
Create
Screeners
Insights
Sunil Healthcare
63.
00
-4.00
(-5.97%)
Market Cap
₹64.60 Cr
PE Ratio
17.14
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-5.97%
1M
-1.87%
6M
-13.07%
1Y
-14.22%
5Y
+98.74%
View Company Insights
Latest news about Sunil Healthcare
Sunil Healthcare FY26 consolidated profit rises, standalone loss reported
2 days ago
Sunil Healthcare Limited reported a consolidated net profit of ₹400.60 lakh for FY26, against a consolidated loss of ₹141.66 lakh in the previous year, while standalone results reflected a net loss of ₹530.21 lakh. The standalone loss was driven by exceptional items of ₹958.25 lakh, including a ₹946.66 lakh provision for a foreign subsidiary and a ₹355.95 lakh write-off for a fire incident at the Alwar plant. The Board approved the audited results on May 29, 2026, and the company published the financial results in newspapers on May 31, 2026.
Sunil Healthcare Schedules Board Meeting on May 29, 2026 to Approve Q4 and FY 2025-26 Audited Financial Results
May 19, 2026
Sunil Healthcare Limited Submits SEBI Compliance Certificate for FY 2025-26
Apr 16, 2026
Sunil Healthcare Limited Receives SEBI Compliance Certificate for Q4 FY26
Apr 07, 2026
Sunil Healthcare Limited Announces Q3 FY26 Financial Results
Feb 06, 2026
More news about Sunil Healthcare
05
Nov 25
Sunil Healthcare Reports Mixed Q2 FY2026 Results with Standalone Profit and Consolidated Loss
Sunil Healthcare Limited announced its Q2 FY2026 results, showing a standalone profit but consolidated loss. Standalone revenue increased to Rs. 235.76 lakhs in Q2, with a profit of Rs. 7.90 lakhs. Half-yearly standalone revenue reached Rs. 461.96 lakhs with a profit of Rs. 50.75 lakhs. However, consolidated operations reported a Q2 loss of Rs. 5.64 lakhs and a half-year loss of Rs. 18.47 lakhs. The Board approved these results on November 4, 2025, with auditors Singhi & Co. conducting a limited review.
Sunil Healthcare
63.
00
-
4.
00
(-
5.
97
%)
1 Year Returns:
-14.22%
Industry Peers
Sun Pharmaceutical
1,789.90
(-
0.
37
%)
Divis Laboratories
6,533.00
(-
0.
31
%)
Torrent Pharmaceuticals
4,317.90
(-
0.
75
%)
Cipla
1,379.30
(-
0.
79
%)
Zydus Life Science
1,078.30
(-
1.
18
%)
Dr Reddys Laboratories
1,274.00
(-
1.
27
%)
Lupin
2,249.80
(-
0.
58
%)
Mankind Pharma
2,299.00
(-
0.
91
%)
Aurobindo Pharma
1,429.20
(-
0.
31
%)
Laurus Labs
1,382.60
(-
0.
42
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar